window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Opinion & Events

  • Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    Colorcon expands global supply network with new pharmaceutical film coating facility in Malaysia

    Colorcon has officially opened a new pharmaceutical film coating manufacturing [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    PacBio brings isoform-level insights to 1000 Genomes Project with HiFi sequencing

    PacBio is contributing long-read transcriptomic data to the 1000 Genomes [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Linus Health to showcase AI tools for brain health detection and trial recruitment at AAIC 2025

    Linus Health will present new findings on its AI-driven cognitive [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Delivery & Formulation,Opinion & Events,Therapeutic Areas

    New research partnership targets $1 malaria prevention shot using next-gen biologics

    Eyam Health, a Canadian biotech, teams with Medicines for Malaria [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Neuraxpharm expands global reach with launch of Australian affiliate

    Neuraxpharm Group, a leading European specialty pharmaceutical company focused on [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Opinion & Events

    NICE recommends first immunotherapy tablet targeting root cause of tree pollen hay fever

    The National Institute for Health and Care Excellence (NICE) has [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    New study shows Aurase wound gel enables painless debridement of chronic wounds

    Peer-reviewed paper highlights pain-free enzymatic approach for venous leg ulcers [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Opinion & Events

    Sorcero acquires Axiom Health to unify AI insights across pharma and medtech

    Sorcero MedTech launch enables single AI platform for drug and [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    OMED Health launches new gastrointestinal treatments and services through personalized health plans

    OMED Health, a UK-based company developing non-invasive breath analysis tools [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Opinion & Events

    Most people with HIV choose long-acting injectables over daily pills

    Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]

    May 5, 2026
Previous111213Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Aravax adds allergy specialists to board as peanut therapy advances
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Therapeutic Areas
  • AI-derived drug candidate reduces fentanyl intake in preclinical opioid study
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top